Pharmaceuticals

Jynneos Market Forecast 2026–2030 Highlighting Expansion Across Industries

May 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Jynneos Market From 2026 To 2030?

Historical growth stemmed from worldwide campaigns to eliminate smallpox, previous monkeypox outbreaks, the creation of more secure vaccinia platforms, governmental preparedness programs, and public health immunization initiatives.

The anticipated expansion in the upcoming period stems from factors such as increasing dangers posed by zoonotic diseases, the enlargement of national vaccine stockpiles, greater financial allocation for biodefense, enhanced global disease monitoring systems, and the broadening of adult vaccination campaigns. Concurrently, significant shifts projected for the forecast period encompass a heightened emphasis on preventing novel infectious diseases, the wider application of non-replicating vaccine technologies, the expansion of government-run immunization schemes, increased strategic vaccine reserves, and growing understanding of zoonotic conditions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20118&type=smp

Which Factors Are Influencing The Growth Of The Jynneos Market?

The jynneos market is projected to grow due to the increasing occurrence of monkeypox cases. Monkeypox, a viral illness caused by the monkeypox virus belonging to the orthopoxvirus family, sees a rise in cases attributed to increased global travel and more significant human-wildlife interactions, which facilitate the rapid spread of infectious agents beyond isolated outbreaks. Jynneos is effective against monkeypox as it provides robust viral prevention for at-risk individuals and is considered safer for those with weakened immune systems compared to traditional smallpox vaccines. For example, in September 2024, the European Centre for Disease Prevention and Control, a Europe-based government agency, reported over 100,000 confirmed cases of pox due to monkeypox virus (MPXV) clade I and clade II, including more than 200 deaths, across over 120 countries globally between January 2022 and July 2024. This increase in monkeypox cases is therefore a primary factor driving the expansion of the Jynneos market.

Jynneos Market Driver: Development Of Combined Vaccines To Enhance Public Health Preparedness

Key companies within the jynneos market are concentrating on developing combined vaccines to simultaneously target multiple diseases. Combined vaccines are immunizations that offer protection against several illnesses with a single injection, thereby reducing the number of shots needed for complete immunization. For instance, in August 2024, Bavarian Nordic A/S, a Denmark-based biotechnology company, announced that Singapore’s Health Sciences Authority (HSA) had approved JYNNEOS (MVA-BN) for preventing smallpox and pox in adults aged 18 and older who are at high risk for these infections. JYNNEOS (MVA-BN) is a non-replicating vaccine specifically designed to be a safer alternative for individuals, including those who are immunocompromised. Its development aims to bolster public health preparedness and address emerging infectious diseases effectively.

Which Segment Categories Are Included In The Jynneos Market Segment Analysis?

The jynneos market covered in this report is segmented –

1) By Indication: Prevention of Monkeypox, Prevention of Smallpox

2) By Formulation: Injectable Formulation, Lyophilized Powder for Reconstitution

3) By Patient Demographics: Adult Patients, Pediatric Patients, High-Risk Populations

4) By Distribution channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Specialty Clinics, Public Health Organizations, Home Healthcare Providers

Who Are The Active Companies Shaping The Jynneos Market?

Major companies operating in the jynneos market are Bavarian Nordic A/S

Get The Full Jynneos Market Report:

https://www.thebusinessresearchcompany.com/report/jynneos-global-market-report

Which Region Is The Leading Market For The Jynneos Market?

North America was the largest region in the jynneos market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the jynneos market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Jynneos Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/jynneos-global-market-report

Browse Through More Reports Similar to the Global Jynneos Market 2026, By The Business Research Company

Market Research Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/market-research-services-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Varenicline Market Report 2026

https://www.thebusinessresearchcompany.com/report/varenicline-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795